Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Cellegy accelerates U.S. filing for Anogesic

Jan. 24, 2001

BioMarin exercises option to product candidate for burns and wounds

Jan. 24, 2001

Phase II trial of P-45 falls short of primary objective

Jan. 23, 2001

Modex completes patient enrollment in EpiDex phase II trial

Jan. 22, 2001

Wyeth-Ayerst seeks FDA approval of new indication of Alesse

Jan. 22, 2001

Meditech licenses Solaraze from SkyePharma

Jan. 22, 2001

Novogen receives grant for development of antiinflammatory drug

Jan. 19, 2001

Development of Fibrostat accelerated in Canada

Jan. 18, 2001

Arakis and Bioglan Pharma to jointly develop novel psoriasis treatment

Jan. 17, 2001

Atrisone advances to phase III testing in acne

Jan. 17, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...